Back
Universal Health Services Vs. Novo Nordisk AS Industry Stock Comparison
Sell
50
UHS
Universal Health Services
Last Price:
$179.99
Seasonality Move:
8.06%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
50
Universal Health Services (UHS)
is a Sell
Is Universal Health Services a Buy, Sell or Hold?
-
The current Universal Health Services [UHS] share price is $180.11. The Score for UHS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
UHS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UHS Stock Price Chart
What is Universal Health Services's stock price today?
-
The Universal Health Services share price today is $180.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UHS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
UHS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.15 | Sell |
| Relative Strength Index (14 RSI): | 30.65 | Sell |
| Chaikin Money Flow: | 730761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (185.31 - 202.01) | Sell |
| Bollinger Bands (100): | (198.67 - 232.41) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.5 | Sell |
| Relative Strength Index (14 RSI): | 19.69 | Sell |
| Chaikin Money Flow: | 20899665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.63 - 110.99) | Sell |
| Bollinger Bands (100): | (107.27 - 131.41) | Sell |
UHS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 183.09 | Sell |
| 20-day SMA: | 192.49 | Sell |
| 50-day SMA: | 204.02 | Sell |
| 200-day SMA: | 197.49 | Sell |
| 8-day EMA: | 182.91 | Sell |
| 20-day EMA: | 190.15 | Sell |
| 50-day EMA: | 200.44 | Sell |
| 200-day EMA: | 195.6 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.71 | Sell |
| 20-day SMA: | 106.65 | Sell |
| 50-day SMA: | 109.28 | Sell |
| 200-day SMA: | 126.25 | Sell |
| 8-day EMA: | 102.07 | Sell |
| 20-day EMA: | 105.53 | Sell |
| 50-day EMA: | 110.02 | Sell |
| 200-day EMA: | 118.09 | Sell |
Universal Health Services Earnings Growth & UHS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.62 per share, and an increase next year of $2.24 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Universal Health Services Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||